Stroke Disorder and Treatment Market: By Type (Diagnostics and Treatment), and By Application (Ischemic Stroke and Haemorrhagic Stroke) - Forecast 2027

ID: VPR/HC/1267 Publishing Year: November 2021 Pages: 155 Format:   


Stroke Disorder and Treatment Market Overview:

The global Stroke Disorder and Treatment Market was valued at $ 31.4 billion in 2020 and is expected to reach $ 54.2 billion by 2027, registering a CAGR of 8.2% from 2021 to 2027.

A stroke is a medical emergency that happens when the blood supply to the brain is cut off, causing brain cells to die. The Stroke Disorder and Treatment Market is driven by an increase in the incidence and prevalence of chronic illnesses. Furthermore, the growing geriatric population will drive the Stroke Disorder and Treatment Market revenue, since older individuals are more susceptible to stroke and need efficient medical treatment to preserve their health. However, the industry is expected to be constrained by high treatment costs and rigorous government restrictions for the licensing of new and advanced equipment and medicines. Furthermore, the World Health Organization (WHO) has developed a worldwide action plan for no communicable disease prevention and control (NCDs). To avoid strokes, heart attacks, and other consequences, the global action plan seeks to decrease NCDs by implementing early diagnosis and cost-effective treatment of hypertension. However, a tight regulatory structure may limit Stroke Disorder and Treatment Market expansion.

The segment's development will be fueled by the availability of well-developed infrastructure as well as emergency care facilities in hospital settings. The growing need for stroke treatment devices in ischemia, haemorrhage, and emergency situations for rapid inspection and detection of the patient's health condition will help the company expand. Furthermore, growing governmental and private sector efforts to reduce hospital costs for different treatments would drive Stroke Disorder and Treatment Market growth.

Key players:

  • AstraZeneca
  • Pfizer Bayer Pharma AG
  • Daiichi Sankyo Novartis AG
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • CARDINAL HEALTH, INC

Segmental Analysis:

The worldwide Stroke Disorder and Treatment Market is segmented into diagnostics and treatments based on type. Diagnostics has the largest market share and is projected to expand at the fastest pace over the next several years. The Stroke Disorder and Treatment Market is being driven by an increase in the use of diagnostic processes such as CT scans, MRIs, and others for the on-time diagnosis of stroke. Because of the rising incidence of ischemic stroke and trauma patients, the ischemic stroke had the largest market share by application.

Regional Analysis:

Globally North America is the biggest market in the world for Stroke Disorder and Treatment, according to regional analysis. This is owing to advancements in stroke therapy. The second-largest market for stroke disease and treatment in Europe. Furthermore, the Asia-Pacific market for Stroke Disorder and Treatment is anticipated to expand at the highest rate.



Frequently Asked Questions
Stroke Disorder and Treatment Market is predicted to grow at 8.2% through forecast period of 2020-2027
By 2027, worth USD 54.2 Billion is estimated for the global market.
The Stroke Disorder and Treatment Market is driven by an increase in the incidence and prevalence of chronic illnesses and the growing geriatric population.
AstraZeneca, Pfizer Bayer Pharma AG, Daiichi Sankyo Novartis AG, ABBOTT LABORATORIES, BOSTON SCIENTIFIC CORPORATION, CARDINAL HEALTH, INC

Type Here for table of content.


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]